Samplix
Samplix is a Danish biotech company developing droplet microfluidics technology for functional single-cell analysis.
Samplix has raised €25M across 1 funding round from 1 investor, most recently a round in Oct 2026. Based in Copenhagen, Denmark; active in Healthtech. Data as of 28 Oct 2026.
Copenhagen, Denmarksamplix.com ↗
Total raised
€25M
€25,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2026-10
latest 2026-10
Funding by year
EUR raised per year · 2026 YTDSamplix — funding by year — interactive chart.
Data table
| Samplix — funding by year | |
|---|---|
| 2026 | €25M |
Signals
High confidenceRaise-next likelihood10
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-28 | Other | €25M | WLanholding GmbH | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData